Technical Analysis for INO - Inovio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 3.29 -3.24% -0.11
INO closed down 3.24 percent on Friday, January 17, 2020, on 70 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical INO trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Golden Cross Bullish -3.24%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.24%
Narrow Range Bar Range Contraction -3.24%
NR7 Range Contraction -3.24%
Inside Day Range Contraction -3.24%
20 DMA Support Bullish -1.79%
Spinning Top Other -1.79%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. The company's DNA-based SynCon technology enables the design of vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza. Its electroporation DNA delivery technology uses controlled electrical pulses to enhance cellular DNA vaccine uptake. The company's clinical programs include human papillomavirus/cervical cancer (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus, hepatitis B virus, human immunodeficiency virus, and malaria vaccines. It is also advancing preclinical research for a seasonal/pandemic influenza vaccine, as well as other products. Inovio Pharmaceuticals, Inc. has collaboration and license agreements with VGX International, Merck, and ChronTech. The company was formerly known as Inovio Biomedical Corporation and changed its name to Inovio Pharmaceuticals, Inc. in May 2010. Inovio Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Blue Bell, Pennsylvania.
Medicine Medical Specialties Infectious Diseases Cancers Prostate Cancer Influenza Vaccination Leukemia Vaccines Virus Influenza Vaccine Malaria Virology Seasonal/Pandemic Influenza Universal Flu Vaccine

Is INO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.11
52 Week Low 1.915
Average Volume 1,055,625
200-Day Moving Average 2.79
50-Day Moving Average 2.82
20-Day Moving Average 3.31
10-Day Moving Average 3.23
Average True Range 0.21
ADX 28.47
+DI 21.49
-DI 16.46
Chandelier Exit (Long, 3 ATRs ) 3.19
Chandelier Exit (Short, 3 ATRs ) 3.20
Upper Bollinger Band 3.68
Lower Bollinger Band 2.94
Percent B (%b) 0.47
BandWidth 22.49
MACD Line 0.13
MACD Signal Line 0.15
MACD Histogram -0.0158
Fundamentals Value
Market Cap 296.84 Million
Num Shares 90.2 Million
EPS -1.07
Price-to-Earnings (P/E) Ratio -3.07
Price-to-Sales 9.78
Price-to-Book 3.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.61
Resistance 3 (R3) 3.62 3.53 3.55
Resistance 2 (R2) 3.53 3.45 3.52 3.53
Resistance 1 (R1) 3.41 3.40 3.37 3.40 3.52
Pivot Point 3.32 3.32 3.30 3.31 3.32
Support 1 (S1) 3.20 3.24 3.16 3.19 3.06
Support 2 (S2) 3.11 3.19 3.10 3.05
Support 3 (S3) 2.99 3.11 3.03
Support 4 (S4) 2.98